Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07708402

Healing Stigma Through Stories

This study is the first phase of the research project. The purpose of this phase is to develop and refine a narrative-based intervention designed to reduce self-stigma among people with schizophrenia.

A small pilot study will be conducted with 24 participants recruited from halfway houses in northern Taiwan. Eligible participants will receive the intervention, which consists of four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma. Participants will complete a workbook during the program, and the written content will be analyzed to better understand their experiences with stigma. Any personal information will be removed to protect participants' privacy. Before and after the intervention, participants will complete questionnaires on self-stigma, depression, social functioning, well-being, hope, and recovery. Information on medication use will also be collected. Group and individual sessions will be audio-recorded for research purposes. The questionnaire data and recordings will be used to evaluate the feasibility and preliminary effects of the intervention.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18 years or older.
  • Diagnosed with schizophrenia or schizoaffective disorder.
  • Clinically stable at the time of study enrollment.
  • Able to communicate in Mandarin Chinese or Taiwanese.
  • Able to read and write and complete study questionnaires.

Exclusion criteria

  • Individuals who lack the capacity to provide informed consent. Decision-making capacity will be assessed using a 10-item true/false questionnaire adapted from Okoli et al. (2018). Participants who answer fewer than 7 questions correctly will be excluded. Those who answer 7 or more questions correctly will receive an additional explanation from the research team. Only individuals who demonstrate a complete understanding of the study after this explanation will be enrolled.
  • Unwilling to have the intervention sessions audio-recorded.

Treatment and study plan

Healing Stigma through Stories

Other

Four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma.

Primary outcomes

  1. The Internalized Stigma of Mental Illness Scale

    Time frame: At baseline(T0) and through study completion, an average of 8 weeks

Secondary outcomes

  1. Beck Depression Inventory-II

    Time frame: At baseline(T0) and through study completion, an average of 8 weeks

  2. Self-Reported Graphic version of the Personal and Social Performance Scale

    Time frame: At baseline(T0) and through study completion, an average of 8 weeks

  3. Subjective Happiness Scale

    Time frame: At baseline(T0) and through study completion, an average of 8 weeks

  4. Herth Hope Index

    Time frame: At baseline(T0) and through study completion, an average of 8 weeks

  5. The questionnaire about the process of recovery

    Time frame: At baseline(T0) and through study completion, an average of 8 weeks

Study contacts

Contact information is provided by the study sponsor or research team.

Li-Ting Huang, phD

CONTACT

[email protected]

+8862-28267284

Sponsors and collaborators

Lead sponsor

National Yang Ming Chiao Tung University

Other

Registry information

Official study title

Healing Stigma Through Stories: Learning From International Practices to Develop and Evaluate a Narrative Program for Individuals With Schizophrenia

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jul 16, 2026
Registry last updated
Jul 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.